CPhI will debut in Philadelphia May 16 – 18, 2017. Combining the CPhI brand with InformEx, the fine and specialty chemical event, CPhI North America will launch its first Connect Conference featuring two educational programs: CPhI Connect, focusing on pharmaceuticals, and InformEx Connect, focusing on fine and specialty chemicals.

Leveraging the expertise of the American Chemical Society (ACS), the U.S. Pharmacopeia (USP), the Society of Chemical Manufacturers and Affiliates (SOCMA), and UBM’s programming resources, the Connect Conference will feature more than 55 speakers and 44 sessions across eight tracks. The conference aims to help industry professionals navigate the rapidly evolving regulatory, strategic and technological landscape.

The CPhI Connect Conference Program include four tracks: Drug Development, Quality/Regulatory, Drug Manufacturing, and Outsourcing. The program will offer perspectives on a variety of pressing pharma and biopharma topics. Speakers include:

• Magid Abou-Gharbia, Ph.D., FRSC, Associate Dean for Research, Laura H. Carnell, Professor of Medicinal Chemistry & Director of the Moulder Center for Drug Discovery Research (MCDDR), School of Pharmacy, Temple University
• Sunny Bhardwaj , Senior Scientist, Merck
• Richard D. Braatz, Ph.D., Edwin R. Gilliland, Professor of Chemical Engineering, Massachusetts Institute of Technology
• David Conlon, Senior Principal Scientist, Bristol-Myers Squibb
• Ian W. Davies, Department of Process and Analytical Chemistry, Merck Research Laboratories, Merck and Co. Inc.
• Amy Ethier, PhD, Formulation Scientist, Skin Delivery, BASF Pharma Solutions
• Robert Garbaccio, Executive Director, Merck
• Stephen V. Hammond, Senior Director/ Team Leader of the Process Analytical Sciences Group, Pfizer Global Technology
• Antonio Hernandez-Cardoso, Senior Scientific Liaison, USP
• Jim Lalonde, SVP of R&D, Codexis Inc.
• D. Jeffery Liu, Ph.D., MBA, MS, Director/Clinical Development Head, ID/IIDPH, RD, GSK
• Ronald T. Piervincenzi, Ph.D., Chief Executive Officer, U.S. Pharmacopeial Convention 
• Yihong Qiu, Oral Drug Products, Manufacturing Science & Technology, AbbVie, Inc.
• David Rabuka, PhD, Global Head of R&D, Chemical Biology, Catalent Biologics – West (formerly Redwood Bioscience), Catalent Pharma Solutions
• Peter D. Senter, Ph.D., Vice President, Chemistry and Senior Distinguished Fellow, Seattle Genetics
• Satish K Singh, Drug Product Services. Lonza Pharma and Biotech, Lonza Ltd
• Arvind Srivastava, Ph.D., Research Advisor, Formulation Development, CMC Development, Eli Lilly and Company
• Pete Stevenson, Vice President and General Manager, Pfizer CentreOne
• Tom Wilson, Vice President, Contract Manufacturing Operations, Pfizer Global Supply & Pfizer CentreOne
• Ron Vladyka, Director of Research & Development, Catalent Pharma Solutions

“We are incredibly excited to host this conference program at CPhI North America in May. The pace of change within the pharmaceutical industry is unprecedented. The Connect program will be a thought-inspiring and educational tool to help attendees navigate these changes.” said Rutger Oudejans, global brand director pharmaceutical, UBM.

To view the full CPhI Connect program visit: schedule.cphinorthamerica.com.